Latest / Washington DC News Today | 2 Min News | The Daily News Now!
FDA Peptide Review Sparks Legal Battle | Washington DC News
The FDA is under fire as it reviews a list of compounded peptides—popular in wellness and longevity circles—that could soon vanish from clinics unless approved. EVEXIAS Life Sciences is suing, claiming the agency unjustly restricted 17 peptides without solid justification. While regulators worry about unapproved drugs, proponents argue regulated compounding pharmacies ensure safety. With demand soaring for alternative treatments, experts urge caution against DIY peptide mixes online—risking contamination and wrong dosages. The FDA’s decision could reshape access to these trending therapies…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.